Georges Fillet

Whole-Body Positron Emission Tomography Using18F-Fluorodeoxyglucose for Posttreatment Evaluation in Hodgkin’s Disease and Non-Hodgkin’s Lymphoma Has Higher Diagnostic and Prognostic Value Than Classical Computed Tomography Scan Imaging

Guy Jérusalem, Yves Béguin, Marie‐France Fassotte et al. · Blood · 1999 · 556 citations

Medicine, Nuclear Medicine, Oncology +16

Prognostic significance of bcl-2 protein expression in aggressive non- Hodgkin's lymphoma. Groupe d'Etude des Lymphomes de l'Adulte (GELA)

Olivier Hermine, Corinne Haïoun, Éric Lepage et al. · Blood · 1996 · 417 citations · Full text

Medicine, Oncology, Pathology +11

Prognostic significance of bcl-2 protein expression in aggressive non- Hodgkin's lymphoma. Groupe d'Etude des Lymphomes de l'Adulte (GELA)

Olivier Hermine, Corinne Haïoun, Éric Lepage et al. · Blood · 1996 · 411 citations · Full text

Medicine, Oncology, Pathology +11

Mitoxantrone versus daunorubicin in induction-consolidation chemotherapy--the value of low-dose cytarabine for maintenance of remission, and an assessment of prognostic factors in acute myeloid leukemia in the elderly: final report. European Organization for the Research and Treatment of Cancer and the Dutch-Belgian Hemato-Oncology Cooperative Hovon Group.

Bob Löwenberg, Stefan Suciu, E Archimbaud et al. · Journal of Clinical Oncology · 1998 · 288 citations · Full text

Medicine, Oncology, Pharmacotherapy +14

Positron emission tomography (PET) with 18F-fluorodeoxyglucose (18F-FDG) for the staging of low-grade non-Hodgkin’s lymphoma (NHL)

Guy Jérusalem, Yves Béguin, Fadi Najjar et al. · Annals of Oncology · 2001 · 268 citations

Medicine, Nuclear Medicine, Oncology +12